Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?

<p>Abstract</p> <p>Since the 1980 s, when cell transplantation into the brain as a cure for Parkinson's disease hit the headlines, several patients with Parkinson's disease have received transplantation of cells from aborted fetuses with the aim of replacing the dopamine...

Full description

Bibliographic Details
Main Author:	Politis Marios
Format:	Article
Language:	English
Published:	BMC 2010-12-01
Series:	BMC Medicine
Online Access:	http://www.biomedcentral.com/1741-7015/8/80

Similar Items

Investigating emotions in Parkinson's disease: what we know and what we still don't know
by: Igor eSotgiu, et al.
Published: (2013-06-01)

Vitamin D and Kidney disease: what we know and what we do not know
by: Antonio Jose Inda Filho, et al.
Published: (2013-12-01)

What We Should Know in Relation to What We Do Know
by: Donald L. Rice
Published: (2014-07-01)

Vaginal Aging—What We Know and What We Do Not Know
by: Jacek K. Szymański, et al.
Published: (2021-05-01)

The origin of life: what we know, what we can know and what we will never know
by: Addy Pross, et al.
Published: (2013-01-01)

Rabies : What We Know and What We Need to Know
by: Sandhu TS
Published: (2004-01-01)

What We Know and What We Do Not Know about Dragon Trees?
by: Petr Maděra, et al.
Published: (2020-02-01)

What do we need to know to know that animals are conscious of what they know?
by: Gary Comstock
Published: (2019-11-01)

We know what we are, but not what we may be
by: Dennis Schauffer
Published: (2006-04-01)

Besnoitiosis in caribou: What we know and what we don't know
by: Julie Ducrocq et al.
Published: (2011-09-01)

Paediatric schistosomiasis: What we know and what we need to know.
by: Derick N M Osakunor, et al.
Published: (2018-02-01)

Interactive maps: What we know and what we need to know
by: Robert E. Roth
Published: (2013-06-01)

Epigenetics in schistosomes: what we know and what we need know
by: Liu Weiwei
Published: (2016-11-01)

Lymphangioleiomyomatosis: what do we know and what are we looking for?
by: O. Torre, et al.
Published: (2011-03-01)

Secondary Metabolites Produced by Heterorhabditis Symbionts and Their Application in Agriculture: What We Know and What to Do Next
by: S. PATRICIA STOCK, et al.
Published: (2017-09-01)

Cognitive Impairment in Parkinson’s Disease: What We Know so Far
by: Painous C, et al.
Published: (2020-07-01)

Multimorbidity: What Do We Know? What Should We Do?
by: Rokas Navickas, et al.
Published: (2016-01-01)

Do we know what we are doing?
by: Andrew Piper

Evolutionary ecology of Chagas disease; what do we know and what do we need?
by: Alheli Flores‐Ferrer, et al.
Published: (2018-04-01)

Pneumonia in Bhutanese children: what we know, and what we need to know
by: Sophie Jullien, et al.
Published: (2020-01-01)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
by: Endurance E Ewere, et al.
Published: (2021-01-01)

Asthma in the elderly: what we know and what we have yet to know
by: Anahí Yáñez, et al.
Published: (2014-01-01)

Contagious itch: what we know and what we would like to know
by: Christina eSchut, et al.
Published: (2015-02-01)

What we know and what we don't know about preventing stroke.
by: Druin Burch, et al.
Published: (2014-04-01)

Prostate Cancer: what we know and what we would like to know
by: Gianluigi eTaverna, et al.
Published: (2015-05-01)

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.
by: Maryam Moazeni, et al.
Published: (2013-09-01)

Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know
by: Chuan-bin Sun, et al.
Published: (2020-04-01)

Determinants of Innovation Cooperation Performance: What Do We Know and What Should We Know?
by: Piotr Trąpczyński, et al.
Published: (2018-11-01)

Evaluation Criteria of Information Retrieval Systems: What We Know and What We Do Not Know
by: Nadjla Hariri, et al.
Published: (2014-12-01)

The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know
by: David S. Goldstein
Published: (2021-06-01)

Angiogenesis: What we know, what we do not understand yet, and what we have to do
by: MARIUS RAICA
Published: (2018-07-01)

What We Know and Do Not Know about Sex and Cardiac Disease
by: John P. Konhilas
Published: (2010-01-01)

Doing What We Know, Knowing What to Do: Californians Linking Action with Science for Prevention of Breast Cancer (CLASP-BC)
by: Jon F. Kerner, et al.
Published: (2020-07-01)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
by: Gürkan Kaya, et al.
Published: (2018-06-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
by: N I Volkova, et al.
Published: (2017-02-01)

Ocular surface inflammation in dry eye disease: What we know and what we do not
by: Jayesh Vazirani
Published: (2018-01-01)

Celiac Disease: What Do We Know in 2017
by: Jorge Amil Dias
Published: (2017-09-01)

Polarization: What Do We Know and What Can We Do About It?
by: Fernando Casal Bértoa, et al.
Published: (2021-06-01)

Galliformes science and species extinctions: what we know and what we need to know
by: P. J. K. McGowan, et al.
Published: (2012-11-01)

Informing Integration: Assessing What We Know, Admitting What We Don’t Know
by: Catherine Dauvergne
Published: (2007-06-01)